3-(cyclopropanecarboxamido)propanoic acid
- $200 - $720
- Product name: 3-(cyclopropanecarboxamido)propanoic acid
- CAS: 874455-57-9
- MF: C7H11NO3
- MW: 157.17
- EINECS:-0
- MDL Number:MFCD07428852
- Synonyms:3-(cyclopropanecarboxamido)propanoic acid;β-Alanine, N-(cyclopropylcarbonyl)-;N-(Cyclopropylcarbonyl)-β-alanine;3-(Cyclopropylformamido)propanoic acid
5 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
- TRC
Package
- 100mg
- 250mg
- 500mg
- 2.500g
- 5g
- ManufacturerAK Scientific
- Product number7668CW
- Product description3-(Cyclopropylformamido)propanoicacid
- Packaging250mg
- Price$291
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD13002796
- Product description3-(Cyclopropanecarboxamido)propanoicacid 95+%
- Packaging5g
- Price$499
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number049316
- Product descriptionN-(Cyclopropylcarbonyl)-beta-alanine
- Packaging500mg
- Price$237
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number049316
- Product descriptionN-(Cyclopropylcarbonyl)-beta-alanine
- Packaging2.500g
- Price$720
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC998363
- Product descriptionN-(Cyclopropylcarbonyl)-β-alanine
- Packaging100mg
- Price$200
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 7668CW | 3-(Cyclopropylformamido)propanoicacid | 250mg | $291 | 2021-12-16 | Buy |
Crysdot | CD13002796 | 3-(Cyclopropanecarboxamido)propanoicacid 95+% | 5g | $499 | 2021-12-16 | Buy |
Matrix Scientific | 049316 | N-(Cyclopropylcarbonyl)-beta-alanine | 500mg | $237 | 2021-12-16 | Buy |
Matrix Scientific | 049316 | N-(Cyclopropylcarbonyl)-beta-alanine | 2.500g | $720 | 2021-12-16 | Buy |
TRC | C998363 | N-(Cyclopropylcarbonyl)-β-alanine | 100mg | $200 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|